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Abstract The Xenopus laevis oocyte has been widely utilized for The receptor for the human complement fragment C3a has 
cloning and functional expression of G-protein coupled receptors recently been cloned and shown to be a seven transmembrane 
(GPCR). This system was used for the functional expression and spanning GPCR with high sequence homology to the recep- 
characterization f the recently identified human C3a receptor, tors for fMLF and C5a [7,8]. We have compared the func- 
Complementary RNA from the human C3a receptor was tional response licited by the C3a and C5a receptors in Xe- 
transcribed in vitro and microinjected into Xenopus oocytes for nopus laevis oocytes and have determined that both of the 
functional characterization. A positive response to a synthetic anaphylatoxins elicit a functional response in oocytes expres- 
C3a peptide agonist and to C3a, but not to platelet activating sing either receptor, however, in each case the cognate ligand 
factor or fMetLeuPhe was detected. In addition, a response of elicits a markedly more robust response than the other ana- 
approximately one third the amplitude obtained with C3a was phylatoxin. Functional expression of the C3a receptor in Xe- 
obtained with rC5a. Conversely, oocytes co-injected with the C5a nopus oocytes is dependent on the presence of a pertussis 
receptor and total RNA isolated from U937 ceils responded to 
C5a as well as to C3a and the C3a synthetic peptide. A toxin sensitive co-factor which can be supplied by co-injection 
functional response with the anaphylatoxin C3a receptor in of total RNA isolated from U937 or HL-60 cells. 
oocytes was dependent on co-injection of a pertussis toxin 
sensitive complementary human factor which could be supplied 2. Materials and methods 
by co-injection of total RNA isolated from U937 cells. Oocytes 
expressing the anaphylatoxin C3a and C5a receptors responded 2.1. Materials 
to both agonists, in each case the response to the cognate ligand The C3a carboxy-terminal analogue synthetic peptide, 
was substantially more robust than the response elicited by the (WWGKKYRASKLGLAR [9]) was obtained from Bachem 
other anaphylatoxin. Bioscience, Inc., King of Prussia, PA. C3a was purchased from Ad- 
vanced Research Technologies, San Diego, CA. Human rC5a was 
expressed in E. coli and purified to homogeneity. Other agonists 
Key words." C3a receptor; C5a receptor; Xenopus laevis and pertussis toxin were obtained from Sigma, St. Louis, MO. The 
oocyte; C3a; C5a; Anaphylatoxin C3a receptor cDNA (HNFAG09) was isolated from a human eutro- 
phil (lipopolysaccharide activated) cDNA library [7]. The C5a recep- 
tor cDNA was isolated via PCR from RNA isolated from dimethyl 
sulfoxide differentiated U937 cells. 
1. Introduction 
2.2. Receptor expression and functional studies in Xenopus oocytes 
Capped cRNA transcripts were generated from linearized C3a re- 
The chemotactic receptors for C5a and the fMLF receptor ceptor and C5a receptor plasmid DNA as previously described [10] 
have previously been functionally expressed in Xenopus laevis and suspended in sterile water at a concentration f 0.2 I.tg/~tl. Ovarian 
oocytes [1-4] and, unlike all other G-protein coupled recep- lobes were surgically removed from adult female Xenopus laevis frogs 
tors (GPCRs) tested in this system, injection of cRNA for the and defolliculated. Stage V oocytes were harvested by manual dissec- 
tion [11]. Oocytes were microinjected with C3a receptor or C5a re- cloned chemotactic receptors alone is insufficient to stimulate ceptor cRNA transcripts (10 ng/oocyte) with or without U937 total 
signal transduction i response to ligand binding [1,2]. Func- RNA (25 ng/oocyte) in a 50 nl volume using a Drummond microin- 
tional expression of both of these chemotactic receptors, as jection apparatus and maintained in modified Barth's saline [12] at 
monitored by induction of Ca 2+ mediated chloride currents, 18°C. Electrophysiological recordings from an average of 10 oocytes 
requires the co-injection of a complementary human factor were made 48 h later at room temperature using the two electrode 
which can be supplied by total RNA from myeloid or liver voltage clamp (Warner Instruments) technique. Some of the oocytes 
were treated with 2 ~tg of pertussis toxin for the last 24 h of the 
cells [1,2]. The co-factor is required for receptor-mediated sig- incubation. Membrane potentials were routinely clamped at -60 
nal transduction but not for expression of the C5a receptor or mY. Results represent average response determined in three separate 
fMLF receptor on the surface of the oocytes [4]. The nature of experiments. 
the co-factor is unknown but it does not appear to be an c~ 
subunit of Gil, Gi2 or Gi3, since co-injection of cRNA for 3. Results and discussion 
fMLF receptor along with these c~ subunits did not induce a 
functional response [2]. In independent s udies, the co-factor Xenopus oocytes were used to functionally characterize the 
has been shown to be encoded by an approximately 3-3.5 kb recently identified human C3a receptor. A C3a carboxy-termi- 
transcript [2,5]. A recent report demonstrated that Gc~-16 nal analogue synthetic peptide (WWGKKYRASKLGLAR 
complements he signal transduction cascade of both the [9]), and to a lesser extent rC5a, but not platelet activating 
C5a and fMLF receptors, and it has been proposed to be factor or the chemotactic peptide fMLF, elicited an electro- 
the complementing co-factor present in HL-60 and U937 [6 ] .  physiological response in oocytes co-injected with cRNA for 
the C3a receptor and total U937 RNA (Fig. 1). Like the C5a 
*Corresponding author. Fax: (1)(610)270-5093. and the fMLF receptors, the response licited by the C3a 
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~t  ~ ~ ' ~  complementary factor present in total RNA from HL-60 
and U937 which is distinct from Gt~-16. 
15o ~ C5a induced rapid activation of chloride currents in C5a 
receptor cRNA plus U937 RNA co-injected oocytes (Fig. 3). 
" / I l l  ~ ,,try-- In addition, in oocytes co-injected with the C5a receptor and 
= lOO total U937 RNA, there was also a smaller esponse to C3a 
C 
(Fig. 3). 
" Both the C5a and C3a receptors elicited in oocytes a pro-  O 
=: 50 ~ miscuous response to the two anaphylatoxins. The responses 
_ ~  detected with the C3a synthetic peptide were not an artifact of 
using the analogue peptide, as the native ligand elicited similar 
0 ' responses in oocytes injected with either receptor (data not 
C3a C3a fMLF PAF C5a  C3a shown). 
o~ ~ RNA In contrast o the promiscuous functional activity of the 
~ - -HNFAG09 + U937-  Injected anaphylatoxin receptors expressed in Xenopus oocytes, RBL- 
Z 
" 2H3 rat basophils expressing the C3a or C5a receptors re- 
Fig. 1. Oocytes expressing C3a receptor espond to both C3a and spond only to their cognate ligand [7]. 
C5a. Electrophysiological response of Xenopus oocytes injected with It is intriguing that the C3a receptor, in oocytes, also elicits 
cRNA for C3 receptor (HNFAG09, 10 ng), total U937 RNA (25 a response to C5a. However, C3a and C5a are very similar in 
ng), or a mixture of C3a receptor (HNFAG09, 10 ng) and U937 size (77 and 74 amino acids, respectively) and in proported 
RNA (25 ng) to 10 nM rC5a, 10 nM C3a analogue peptide, 10 nM structure [14]. In fact, the crystal structure of C3a has been 
platelet activating factor (PAF), 10 nM fMetLeuPhe. Inset presents 
typical response of oocytes co-injected with C3a receptor used to derive a model of C5a [15]. In addition to C3a and 
cRNA+U937 RNA to 10 nM C3a. C5a receptors, we have observed other instances in which the 
responses in oocytes are more promiscuous than the response 
elicited by the same receptor expressed in mammalian cells. 
receptor was dependent on the co-injection of a co-factor For example, oocytes injected with calcitonin gene related 
present in total U937 RNA, as C3a receptor cRNA or peptide (CGRP)receptor respond both to CGRP and calci- 
U937 RNA when injected alone did not elicit any response tonin, while mammalian cells transfected with the CGRP re- 
to the C3a synthetic peptide or rC5a (Fig. 1). The exact nature ceptor respond only to CGRP (unpublished observation). 
of the co-factor is not known, however as the response to the There are other examples of anomalous behavior of cloned 
C3a peptide of oocytes co-injected with C3a receptor and receptors using the oocytes ystem, most notably the misiden- 
U937 RNA was abolished by pertussis toxin (Fig. 2), it tification of the mas oncogene as an angiotensin receptor [16]. 
does not appear to be Gt~-16, which lacks a pertussis toxin It was later demonstrated that rather than encoding an angio- 
ADP-ribosylation site [13]. Gc(-16 is encoded by a 2.2 kb [13] tensin receptor, the expression of the mas oncogene in oocytes 
transcript, a size significantly smaller than the 3.5 kb RNA leads to increased responsiveness of the endogenous All sig- 
fraction which complements he C5a and fMLF receptor ex- nailing system [17]. These data exemplify the importance of 
pression [2,5]. Although Gc(-16 is present in myeloid cells and critical interpretation of the results obtained with cloned 
can complement the functional expression of the C5a and GPCRs in Xenopus oocytes. 
fMLF receptors in Xenopus oocytes, there appears to be a In summary, we have demonstrated that like the C5a and 
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Fig. 2. Pertussis toxin treatement of oocytes co-injected with C3a re- 
ceptor and total U937 RNA abolishes the response licited by C3a. Fig. 3. Electrophysiological response of oocytes injected with C5a 
Whole cell currents of oocytes exposed to 10 nM C3a analogue pep-  receptor cRNA (CD88, 10 ng), U937 RNA (25 ng) or a mixture of 
tide. Oocytes were injected with a mixture of cRNA for C3a recep- C5a receptor and U937 RNA, to 10 nM rC5a or 10 nM C3a ana- 
tor (HNFAG09, 10 ng) and U937 RNA. Cells were treated with logue peptide. Inset, represents ypical response of oocytes co-in- 
perutssis toxin (2 gg, A), or untreated (B). jected with C5a receptor cRNA+U937 RNA to 10 nM rC5a. 
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fMLF receptors, the C3a receptor is functionally active in [7] Ames, R.S., Li, Y., Sarau, H.M., Nuthulaganti, P., Foley, J.J., 
Xenopus oocytes, and that activity is dependent on a pertussis Ellis, C., Zeng, Z., Su, K., Jurewicz, A.J., Hertzberg, R.P., Bergs- 
ma, D.J. and Kumar, C. (1996) J. Biol. Chem. 271, 20231 20234. 
toxin sensitive co-factor present in total RNA isolated from [8] Crass, T., Raffetseder, U., Martin, U., Grove, M., Klos, A., 
myeloid cell lines. In addition, we have demonstrated that Kohl, J. and Bautsch, W. (1996) Eur. J. Immunol. 26, 1944-1950. 
both anaphylatoxin receptors, in oocytes, are capable of inter- [9] Ember, J.A., Johansen, N.L. and Hugli, T.E. (1991) Biochemistry 
acting with both anaphylatoxins however, both receptors elicit 30, 3603-3612. 
a maximal response to their cognate ligand. [10] Kumar, C.S., Muthukumaran, G., Frost, L.J., Noe, M., Ahn, Y., 
Mariano, T.M. and Pestka, S. (1989) J. Biol.Chem. 264, 17939- 
17946. 
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